Crunch announced Monday morning that it was being acquired by TPG Growth. But why was now the right time to sell? Here's what Jim Rowley, CEO of Crunch has to say.
Let's stand back a little and get some perspective on how prices have behaved.
Wall Street woke up to another major deal. Here's what to watch from AbbVie's acquistion of Allergan, Warren Buffett's Kraft comments and Micron earnings after the bell.
At first glance, CGC's report looks like a drag, but you must dig into the weeds to see how timing and the industry are at play.
DHR shares are up 35% in 2019.
Let's check the charts and indicators on the glucose-monitoring company.
No one knows their business as well as the CEO.
The company says the test revealed patients were experiencing 'deepening and durability of response over time' with the treatment.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.